Technical Analysis for IPHA - Innate Pharma S.A.

Grade Last Price % Change Price Change
F 2.39 -5.35% -0.14
IPHA closed down 5.35 percent on Monday, March 18, 2024, on 89 percent of normal volume.
Earnings due: Mar 21
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
BB Squeeze Ended Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Bollinger Band Squeeze Range Contraction -5.35%
BB Squeeze + Lower Band Touch Range Contraction -5.35%
Outside Day Range Expansion -5.35%

   Recent Intraday Alerts

Alert Time
Reversed from Down about 14 hours ago
Rose Above 20 DMA about 14 hours ago
Rose Above Previous Day's High about 14 hours ago
Rose Above 10 DMA about 14 hours ago
Up 3% about 14 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Innate Pharma SA is a biopharmaceutical company, which focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. Its products include immunotherapy drugs and monoclonal antibodies. The Immunotherapy drugs are designated for cancer and inflammatory diseases. The Monoclonal antibodies targets receptors and pathways controlling the activation of innate immunity cells. The company was founded by Hervé Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié and François Romagné on September 15, 1999 and is headquartered in Marseille, France.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Immunology Immune System Immunotherapy Antibodies Cancer Treatment Monoclonal Antibodies Monoclonal Antibody Antibody Inflammatory Diseases Immunity

Is IPHA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.57
52 Week Low 1.81
Average Volume 8,575
200-Day Moving Average 2.74
50-Day Moving Average 2.63
20-Day Moving Average 2.58
10-Day Moving Average 2.55
Average True Range 0.16
RSI (14) 40.83
ADX 21.82
+DI 12.65
-DI 23.72
Chandelier Exit (Long, 3 ATRs) 2.22
Chandelier Exit (Short, 3 ATRs) 2.82
Upper Bollinger Bands 2.73
Lower Bollinger Band 2.43
Percent B (%b) -0.12
BandWidth 11.82
MACD Line -0.03
MACD Signal Line -0.02
MACD Histogram -0.0164
Fundamentals Value
Market Cap 193.21 Million
Num Shares 80.8 Million
EPS -0.85
Price-to-Earnings (P/E) Ratio -2.81
Price-to-Sales 3.87
Price-to-Book 3.24
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.75
Resistance 3 (R3) 2.78 2.69 2.69
Resistance 2 (R2) 2.69 2.60 2.68 2.67
Resistance 1 (R1) 2.54 2.54 2.62 2.51 2.65
Pivot Point 2.45 2.45 2.49 2.44 2.45
Support 1 (S1) 2.30 2.36 2.38 2.27 2.13
Support 2 (S2) 2.21 2.30 2.19 2.11
Support 3 (S3) 2.06 2.21 2.09
Support 4 (S4) 2.03